6-phosphogluconolactonase
6-Phosphogluconolactonase (6PGL) is an enzyme that plays a crucial role in the pentose phosphate pathway (PPP), a metabolic pathway parallel to glycolysis, primarily responsible for the oxidation of glucose to generate NADPH and ribose 5-phosphate. NADPH is essential for biosynthetic reactions and antioxidant defense, while ribose 5-phosphate is a precursor for the synthesis of nucleotides and nucleic acids.
Function[edit | edit source]
6-Phosphogluconolactonase catalyzes the hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate. This reaction is the second step in the oxidative phase of the pentose phosphate pathway. The enzyme ensures the smooth progression from 6-phosphogluconolactone, produced by the oxidation of glucose-6-phosphate via the enzyme glucose-6-phosphate dehydrogenase (G6PD), to 6-phosphogluconate. Subsequently, 6-phosphogluconate is further metabolized to ribulose-5-phosphate by the enzyme 6-phosphogluconate dehydrogenase, with the concurrent production of NADPH.
Structure[edit | edit source]
6-Phosphogluconolactonase is a protein that can vary in structure among different species. However, it typically functions as a monomer or homodimer in cells. The enzyme's active site is responsible for binding the substrate, 6-phosphogluconolactone, and catalyzing its hydrolysis to 6-phosphogluconate. The precise structure of 6PGL and the mechanism of action are subjects of ongoing research, aiming to understand how the enzyme achieves its specificity and efficiency.
Genetic Regulation[edit | edit source]
The gene encoding 6-phosphogluconolactonase is regulated in a manner consistent with its role in cellular metabolism. In response to cellular needs for NADPH and ribose 5-phosphate, the expression of the enzyme can be upregulated or downregulated. This regulation ensures that the pentose phosphate pathway operates efficiently under varying cellular conditions, such as oxidative stress or during periods of rapid cell growth and division.
Clinical Significance[edit | edit source]
Alterations in the activity of 6-phosphogluconolactonase can have implications for human health. Although direct diseases associated with 6PGL deficiency are rare, the enzyme's role in the pentose phosphate pathway links it to conditions related to impaired NADPH production and antioxidant defense. For example, mutations in the glucose-6-phosphate dehydrogenase enzyme can lead to G6PD deficiency, a condition that results in reduced NADPH levels and increased vulnerability to oxidative stress. Understanding the function and regulation of 6-phosphogluconolactonase can contribute to better insights into metabolic diseases and the development of therapeutic strategies.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD